EUCTR2013-002165-19-NL进行中（未招募）不适用
Hypernatraemia and diuretics
Medical Center Leeuwarden0 个研究点开始时间: 2013年7月25日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •admission in the intensive care
- •age > 18 years
- •sodium level in plasma > 142 mmol/L
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 20
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 30
排除标准
- •sodium level > 142 mmol/L before admission
- •no informed consent
- •diabetes insipidus
研究者
相似试验
已完成
不适用
Hydrochloorthiazide and HypernatriaemieHypernatraemiaNCT01974739Medical Centre Leeuwarden50
进行中（未招募）
1 期
THE BALANCE Study: Treatment of Hyponatremia Based on Lixivaptan in NYHA Class III/IV Cardiac Patient EvaluatioHyponatremiaEUCTR2006-002567-62-SKCardiokine Biopharma, LLC650
进行中（未招募）
不适用
THE BALANCE Study: Treatment of Hyponatremia Based on Lixivaptan in NYHA Class III/IV Cardiac Patient EvaluatioMedDRA version: 9.1Level: LLTClassification code 10021038Term: HyponatremiaHyponatremiaEUCTR2006-002567-62-CZCardiokine Biopharma, LLC650
进行中（未招募）
不适用
THE BALANCE Study: Treatment of Hyponatremia Based on Lixivaptan in NYHA Class III/IV Cardiac Patient EvaluationEstudio BALANCE: Tratamiento de la Hyponatremia mediante lixivaptan en la evaluación del paciente con insuficiencia cardiaca con Clase III/IV de la NYHAHyponatremiaHiponatremiaMedDRA version: 9.1Level: LLTClassification code 10021038Term: HyponatremiaEUCTR2006-002567-62-ESCardiokine Biopharma, LLC650
进行中（未招募）
不适用
THE BALANCE Study: Treatment of Hyponatremia Based on Lixivaptan in NYHA Class III/IV Cardiac Patient EvaluatioMedDRA version: 9.1Level: LLTClassification code 10021038Term: HyponatremiaHyponatremiaEUCTR2006-002567-62-DECardiokine Biopharma, LLC650